Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,080 public trials 582 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Participants

NCT00622505

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • TriValley Cancer Research and Treatment Center Casa Grande, Arizona, United States
  • Wilshire Oncology Medical Group La Verne, California, United States
  • Cedars Sinai Medical Center Outpatient Cancer Ctr. (4) Los Angeles, California, United States
  • Palo Alto Medical Foundation Hematology/Oncology Mountain View, California, United States
View all 42 locations
View Trial Details
Completed

Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)

NCT02669017

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Burkitt's Lymphoma, +39 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients

NCT01018979

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations
  • Chang-Gung Memorial Hospital Chiayi Chiayi City, Taiwan
  • Buddist Tzu Chi General Hospital Hualien City, Taiwan
  • Kaohsiung Medical University Hospital Kaohsiung City, Taiwan
  • Chang-Gung Memorial Hospital Linkou Linkou District, Taiwan
View Trial Details

Related conditions